Bharat Biotech

Bharat Biotech's TB vaccine MTBVAC begins clinical trials in India

By Connect Gujarat Desk 24 Mar 2024

Business

Bharat Biotech's intranasal covid vaccine priced at ₹325 for govt hospitals

iNCOVACC will also be available on the CoWin platform and will be rolled out in the fourth week of January

By Connect Gujarat Desk 27 Dec 2022

Share LinkedIn

Health & Fitness

Covaxin cleared for kids aged 6 to 12 years

Bharat Biotech asked to keep submitting safety data

By Connect Gujarat Desk 26 Apr 2022

Share LinkedIn

Health & Fitness

India gives nod to Bharat Biotech's nasal COVID booster to conduct trials

Hyderabad-based manufacturer Bharat Biotech on Friday was given a go-ahead by the DGCI to conduct trials of its intranasal COVID booster dose in the country.

By Connect Gujarat Desk 28 Jan 2022

Share LinkedIn

Health & Fitness

Bharat Biotech gets DCGI nod to test nasal COVID-19 vaccine as booster shot

Hyderabad-based vaccine manufacturer Bharat Biotech on Wednesday got 'in principle' approval from the country's drug regulator to test nasal COVID-19 vaccine as a booster shot.

By Connect Gujarat Desk 05 Jan 2022

Share LinkedIn

Health & Fitness

Today begins the COVID-19 vaccination for 15-18 age group

Only Bharat Biotech's 'Covaxin' would be provided in this population segment, according to the Union Health Ministry

By Connect Gujarat Desk 03 Jan 2022

Share LinkedIn

Health & Fitness

Bharat Biotech's Covaxin will be approved for emergency use by the WHO's Technical Advisory Group today

The technical panel had previously requested further explanations from Bharat Biotech to complete a final risk-benefit analysis for global use of the vaccine.